Topically Applied Peptides & Neuropeptides

Lupo MP. Cosmeceutical peptides. Dermatol Surg. 2005 Jul;31(7 Pt 2):832-6; discussion 836. Department of Dermatology, Tulane University School of Medicine, New Orleans, LA 70124, USA.

Jia C, Chen B. The influence of N-terminal sequence peptide of alpha-smooth muscle actin on wound contraction. Zhonghua Shao Shang Za Zhi. 2002 Jun;18(3):166-9. Department of Burns, Xijing Hospital, The Fourth Military Medical University, Xian 710032, Shan Xi Province, P.R. China.

Lu MY, Lee D, Rao GS. Percutaneous absorption enhancement of leuprolide. Pharm Res. 1992 Dec;9(12):1575-9. Pharmaceutical Products Division, Abbott Laboratories, North Chicago, Illinois 60064.

Veronesi B, Sailstad DM, Doerfler DL, Selgrade M. Neuropeptide modulation of chemically induced skin irritation. Toxicol Appl Pharmacol. 1995 Dec;135(2):258-67. U.S. Environmental Protection Agency, National Health and Environmental Effects Research Laboratory, Research Triangle Park, North Carolina 27711, USA.

Mazue G, Bertolero F, Jacob C, Sarmientos P, Roncucci R. Preclinical and clinical studies with recombinant human basic fibroblast growth factor. Ann N Y Acad Sci. 1991;638:329-40. Farmitalia Carlo Erba, Erbamont Group, Milan, Italy.